Similar companies
| Company | X Mentions | |
|---|---|---|
 |
Johnson & JohnsonJNJ |
39 39.1% |
 |
Eli Lilly and CompanyLLY |
85 37% |
 |
PfizerPFE |
82 13.7% |
 |
AstrazenecaAZN |
8 63.6% |
 |
AbbVieABBV |
31 55% |
Month over Month
Est. daily mentions of Cashtag on X.
| Jan 2026 | 6 | |
| Dec 2025 | 2 | |
| Nov 2025 | 5 | |
| Oct 2025 | 13 |
Analyzing X Mentions, how is TherapeuticsMD performing compared to its industry peers?
TherapeuticsMD underperforms its industry peers when it comes to X Mentions, ranking in the 4th percentile.
Why should an investor track X mentions?
Investors should track mentions of TherapeuticsMD on X because sudden increases in activity often reflect shifts in retail interest, sentiment, or breaking news. These signals can precede sharp price movements, offering valuable context for timing trades or identifying emerging opportunities.
Sign up and get more insights on TherapeuticsMD.
Sentiment on X
The sentiment score for TherapeuticsMD on X is 87 (out of 100). This is considered bullish. Sentiment today is up compared to the 30 moving average.
